About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 1378 record(s)
Req # A-2020-001043
Adverse Drug Reactions (ADRs). Report numbers: 000725078, 000725080, 000725230, 000725255, 000725292, 000725339, 000725341, 000725360, 000725364, 000725369, 000725377, 000725379, 000725380, 000725415, 000725417, 000725425, 000725504, 000725716, 000725749, 000725829.Organization: Health Canada
December 2021
Req # A-2020-001252
Adverse Drug Reactions (ADRs) Emend, Estrogel, Ezetrol. Report numbers: E2B_01263843, E2B_01263849, E2B_00277833, E2B_01667256, 000614905, 000633506, 000641862, 00695904, 000696447, 000696713.Organization: Health Canada
December 2021
Req # A-2020-001328
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-113237-952.Organization: Health Canada
December 2021
Req # A-2020-001560
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115403-103.Organization: Health Canada
December 2021
Req # A-2020-001564
Adverse Drug Reactions (ADRs). Report numbers: E2B_03221028, E2B_03221728, E2B_03221852, E2B_03222250, E2B_03223435, E2B_03223436, E2B_03223464, E2B_03223466, E2B_03223473, E2B_03223478, E2B_03223658, E2B_03224675, E2B_03225421, E2B_03225455, E2B_03225684, E2B_03226685, E2B_03226878, E2B_03228284, E2B_03228532, E2B_03230065.Organization: Health Canada
December 2021
Req # A-2020-001682
Adverse Drug Reactions (ADRs). Report numbers: E2B_03361270, E2B_03292659, E2B_03333792, E2B_03297856, E2B_03288214, E2B_03342866, E2B_03386949, E2B_03278465, E2B_03401712, E2B_03402109, E2B_03383022, E2B_03390637, E2B_03286279, E2B_03287731, E2B_03366077, E2B_03280916, E2B_03288216, E2B_03287703, E2B_03287705, E2B_03288047.Organization: Health Canada
December 2021
Req # A-2020-001807
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114477-391.Organization: Health Canada
December 2021
Req # A-2020-001892
Adverse Drug Reactions (ADRs) for Januvia. Report numbers: E2B_01476232, 000700596, 000700172, 000702831, E2B_00412992, 000706797. ADRs for Keytruda. Report numbers: 000696124, 000699458, 000699544.Organization: Health Canada
December 2021
Req # A-2021-000021
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-116090-508.Organization: Health Canada
December 2021
Req # A-2021-000038
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-117847-945.Organization: Health Canada
December 2021